Literature DB >> 6974538

Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.

Y C Girouard, I W Maclean, A R Ronald, W L Albritton.   

Abstract

The susceptibility of 47 strains of Haemophilus ducreyi to amoxicillin, clavulanic acid, and the combination of both drugs was determined by agar dilution susceptibility testing. A synergistic antibacterial activity of the combination was found for beta-lactamase-producing strains.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6974538      PMCID： PMC181647          DOI： 10.1128/AAC.20.1.144

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Chancroid: alias the soft chancre.

Authors:  A Gaisin; C L Heaton
Journal:  Int J Dermatol       Date:  1975-04       Impact factor: 2.736

2.  [New therapeutic viewpoints on ulcus molle].

Authors:  G Lüders; J Braun; F Pietzcker; D Schüle
Journal:  Hautarzt       Date:  1975-01       Impact factor: 0.751

3.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

Authors:  A G Brown; D Butterworth; M Cole; G Hanscomb; J D Hood; C Reading; G N Rolinson
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

5.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

6.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

7.  The management of resistant chancroid in Vietnam.

Authors:  J L Marmar
Journal:  J Urol       Date:  1972-05       Impact factor: 7.450

8.  Treatment of chancroid. A comparison of tetracycline and sulfisoxazole.

Authors:  R E Kerber; C E Rowe; K R Gilbert
Journal:  Arch Dermatol       Date:  1969-11

9.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191
View more
  5 in total

1.  Susceptibility of Haemophilus ducreyi to ampicillin and sulbactam in vitro.

Authors:  B M Jones; S Hafiz; B I Duerden
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.

Authors:  K E Aldridge; C Cammarata; D H Martin
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

4.  In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.

Authors:  J S Knapp; A F Back; A F Babst; D Taylor; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

5.  Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.

Authors:  M Motley; S K Sarafian; J S Knapp; A A Zaidi; G Schmid
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.